These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28674521)

  • 21. The incretin effect in critically ill patients: a case-control study.
    Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
    Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic Exposure to TNFα Impairs Secretion of Glucagon-Like Peptide-1.
    Gagnon J; Sauvé M; Zhao W; Stacey HM; Wiber SC; Bolz SS; Brubaker PL
    Endocrinology; 2015 Nov; 156(11):3950-60. PubMed ID: 26270730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ghrelin secretion is inhibited by glucose load and insulin-induced hypoglycaemia but unaffected by glucagon and arginine in humans.
    Broglio F; Gottero C; Prodam F; Destefanis S; Gauna C; Me E; Riganti F; Vivenza D; Rapa A; Martina V; Arvat E; Bona G; van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):503-9. PubMed ID: 15473884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
    Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
    Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nesfatin-1 stimulates glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide secretion from STC-1 cells in vitro.
    Ramesh N; Mortazavi S; Unniappan S
    Biochem Biophys Res Commun; 2015 Jun; 462(2):124-30. PubMed ID: 25930999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
    Seino Y; Maekawa R; Ogata H; Hayashi Y
    J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):27-32. PubMed ID: 27186352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1.
    Tong J; Davis HW; Gastaldelli A; D'Alessio D
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2405-14. PubMed ID: 27055279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
    Meier JJ; Holst JJ; Schmidt WE; Nauck MA
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice.
    Baggio L; Kieffer TJ; Drucker DJ
    Endocrinology; 2000 Oct; 141(10):3703-9. PubMed ID: 11014225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.
    Nauck MA; Holst JJ; Willms B; Schmiegel W
    Exp Clin Endocrinol Diabetes; 1997; 105(4):187-95. PubMed ID: 9285204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP-1(7-36)) amide in C57BL/6J mice.
    Fujii Y; Osaki N; Hase T; Shimotoyodome A
    J Nutr Sci; 2015; 4():e9. PubMed ID: 26097706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines.
    Pacheco-Pantoja EL; Dillon JP; Wilson PJ; Fraser WD; Gallagher JA
    Purinergic Signal; 2016 Dec; 12(4):647-651. PubMed ID: 27439698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone and insulin stimulate ghrelin secretion of broilers in a different way.
    Song X; Jiao H; Zhao J; Wang X; Lin H
    Gen Comp Endocrinol; 2018 Nov; 268():14-21. PubMed ID: 30016627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP-1, and insulin secretion.
    Zengul AG; Hoover SE; Chandler-Laney PC
    Pediatr Obes; 2021 Jun; 16(6):e12757. PubMed ID: 33236516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.